These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 24188201)

  • 1. Regulation of cigarette smoke-induced toll-like receptor 4 expression by peroxisome proliferator-activated receptor-gamma agonists in bronchial epithelial cells.
    Yin Y; Hou G; Li ER; Wang QY; Kang J
    Respirology; 2013 Nov; 18 Suppl 3():30-9. PubMed ID: 24188201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPARγ agonists regulate tobacco smoke-induced Toll like receptor 4 expression in alveolar macrophages.
    Yin Y; Hou G; Li E; Wang Q; Kang J
    Respir Res; 2014 Mar; 15(1):28. PubMed ID: 24612634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor gamma agonist rosiglitazone attenuates oxyhemoglobin-induced Toll-like receptor 4 expression in vascular smooth muscle cells.
    Wu Y; Zhao XD; Zhuang Z; Xue YJ; Cheng HL; Yin HX; Shi JX
    Brain Res; 2010 Mar; 1322():102-8. PubMed ID: 20132800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulated peroxisome proliferator-activated receptor γ (PPARγ) in lung epithelial cells promotes a PPARγ agonist-reversible proinflammatory phenotype in chronic obstructive pulmonary disease (COPD).
    Lakshmi SP; Reddy AT; Zhang Y; Sciurba FC; Mallampalli RK; Duncan SR; Reddy RC
    J Biol Chem; 2014 Mar; 289(10):6383-6393. PubMed ID: 24368768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of NF-kappaB and PPAR-gamma in lung inflammation induced by monocyte-derived microparticles.
    Neri T; Armani C; Pegoli A; Cordazzo C; Carmazzi Y; Brunelleschi S; Bardelli C; Breschi MC; Paggiaro P; Celi A
    Eur Respir J; 2011 Jun; 37(6):1494-502. PubMed ID: 21148223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats.
    Liu DS; Liu WJ; Chen L; Ou XM; Wang T; Feng YL; Zhang SF; Xu D; Chen YJ; Wen FQ
    Toxicology; 2009 Jun; 260(1-3):112-9. PubMed ID: 19464576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, PPARgamma agonists, differentially regulate cigarette smoke-mediated pro-inflammatory cytokine release in monocytes/macrophages.
    Caito S; Yang SR; Kode A; Edirisinghe I; Rajendrasozhan S; Phipps RP; Rahman I
    Antioxid Redox Signal; 2008 Feb; 10(2):253-60. PubMed ID: 17970647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone attenuates the metalloprotease/anti-metalloprotease imbalance in emphysema induced by cigarette smoke: involvement of extracellular signal-regulated kinase and NFκB signaling.
    Hou G; Yin Y; Han D; Wang QY; Kang J
    Int J Chron Obstruct Pulmon Dis; 2015; 10():715-24. PubMed ID: 25897215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of the peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist, rosiglitazone and antagonist, biphenol-A-diglicydyl ether (BADGE) on the course of inflammation in the experimental model of colitis in rats.
    Dworzanski T; Celinski K; Korolczuk A; Slomka M; Radej S; Czechowska G; Madro A; Cichoz-Lach H
    J Physiol Pharmacol; 2010 Dec; 61(6):683-93. PubMed ID: 21224499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbocysteine regulates innate immune responses and senescence processes in cigarette smoke stimulated bronchial epithelial cells.
    Pace E; Ferraro M; Siena L; Scafidi V; Gerbino S; Di Vincenzo S; Gallina S; Lanata L; Gjomarkaj M
    Toxicol Lett; 2013 Nov; 223(2):198-204. PubMed ID: 24076166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effects of pioglitazone in a rat model of permanent focal cerebral ischemia are associated with peroxisome proliferator-activated receptor gamma-mediated suppression of nuclear factor-κB signaling pathway.
    Zhang HL; Xu M; Wei C; Qin AP; Liu CF; Hong LZ; Zhao XY; Liu J; Qin ZH
    Neuroscience; 2011 Mar; 176():381-95. PubMed ID: 21185913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia.
    Liu D; Zeng BX; Zhang SH; Yao SL
    Inflamm Res; 2005 Nov; 54(11):464-70. PubMed ID: 16307220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor gamma agonist down-regulates IL-17 expression in a murine model of allergic airway inflammation.
    Park SJ; Lee KS; Kim SR; Min KH; Choe YH; Moon H; Chae HJ; Yoo WH; Lee YC
    J Immunol; 2009 Sep; 183(5):3259-67. PubMed ID: 19641141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARγ agonist suppresses TLR4 expression and TNF-α production in LPS stimulated monocyte leukemia cells.
    Wang CZ; Zhang Y; Li XD; Hu Y; Fang ZG; Lin DJ; Xiao RZ; Huang RW; Huang HQ; Liu PQ; Liu JJ
    Cell Biochem Biophys; 2011 Jul; 60(3):167-72. PubMed ID: 21104157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of peroxisome proliferator-activated receptors-gamma ligands on dextran sodium sulphate-induced colitis in rats.
    Celinski K; Dworzanski T; Korolczuk A; Piasecki R; Slomka M; Madro A; Fornal R
    J Physiol Pharmacol; 2011 Jun; 62(3):347-56. PubMed ID: 21893696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein triggers inflammatory responses partly via TLR4/IRF3/NF-κB signaling pathway in rat vascular smooth muscle cells.
    Liu N; Liu JT; Ji YY; Lu PP
    Life Sci; 2010 Sep; 87(11-12):367-74. PubMed ID: 20670634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome Proliferator Activated Receptor gamma (PPARγ) Agonist Rosiglitazone Ameliorate Airway Inflammation by Inhibiting Toll-Like Receptor 2 (TLR2)/Nod-Like Receptor with Pyrin Domain Containing 3 (NLRP3) Inflammatory Corpuscle Activation in Asthmatic Mice.
    Cheng Y; Li S; Wang M; Cheng C; Liu R
    Med Sci Monit; 2018 Dec; 24():9045-9053. PubMed ID: 30544130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, Attenuates Inflammation Via NF-κB Inhibition in Lipopolysaccharide-Induced Peritonitis.
    Zhang YF; Zou XL; Wu J; Yu XQ; Yang X
    Inflammation; 2015 Dec; 38(6):2105-15. PubMed ID: 26047949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
    Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
    Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.